Search results for "atrial fibrillation"

showing 10 items of 410 documents

Re-interpreting complex atrial tachycardia maps using global atrial vectors.

2021

Activation maps of scar-related atrial tachycardias (AT) can be challenging to interpret due to difficulty in inaccurate annotation of electrograms, and an arbitrarily predefined mapping window. A novel mapping software integrating vector data and applying an algorithmic solution taking into consideration global activation pattern has been recently described (Coherent™, Biosense Webster "Investigational").We aimed to assess the investigational algorithm to determine the mechanism of AT compared with the standard algorithm.This study included patients who underwent ablation of scar-related AT using the Carto 3 and the standard activation algorithm. The mapping data were analyzed retrospectiv…

medicine.medical_specialtymedicine.medical_treatmenteducation030204 cardiovascular system & hematologyArticleCicatrix03 medical and health sciences0302 clinical medicineTachycardiaPhysiology (medical)Internal medicineTachycardia SupraventricularMedicineHumansIn patientProspective Studiescardiovascular diseases030212 general & internal medicineHeart AtriaAtrial tachycardiaRetrospective Studiesbusiness.industryfood and beveragesAtrial fibrillationmedicine.diseaseAblationCatheter Ablationcardiovascular systemCardiologymedicine.symptomElectrophysiologic Techniques CardiacCardiology and Cardiovascular MedicinebusinessAlgorithmsJournal of cardiovascular electrophysiologyREFERENCES
researchProduct

Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge.

2020

Background Atrial fibrillation is the most frequent cardiac arrhythmia. It has been estimated that 6–12 million people worldwide will suffer this condition in the US by 2050 and 17.9 million people in Europe by 2060. Atrial fibrillation is a major risk factor for ischemic stroke and provokes important economic burden along with significant morbidity and mortality. Aim We provide here comprehensive and updated statistics on worldwide epidemiology of atrial fibrillation. Methods An electronic search was conducted for atrial fibrillation. The epidemiologic information was retrieved from the Global Health Data Exchange database, which is regarded as one of the most comprehensive worldwide catal…

medicine.medical_specialtymorbidityGlobal HealthpreventionEpidemiologyAtrial FibrillationmedicinePrevalenceHumansIntensive care medicineEpidemicsFibrillationbusiness.industryscreeningPublic healthIncidenceCardiac arrhythmiaAtrial fibrillationmedicine.diseasemortalityAtrial fibrillation; epidemiology; morbidity; mortality; prevention; screeningStrokeNeurologyepidemiologyPublic Healthmedicine.symptombusinessInternational journal of stroke : official journal of the International Stroke Society
researchProduct

Impact of Metabolic Status on the Course of Atrial Fibrillation

2018

Abstract Background and aims: Metabolic syndrome (MS) might influence the course of atrial fibrillation (AF) similarly to diabetes (DM). Aim of this research is to evaluate the quality of life, disease burden and medication adherence of patients with different metabolic states. Material and methods: A cross-sectional study of Latvian Center of Cardiology Arrhythmology Department patients with AF, sorting patients in 3 categories according to the National Institutes for Health guidelines criteria for MS. Results: From 133 patients, 51 were in metabolically healthy (MH) group, 58 in MS group and 24 had DM. Average age was 62.59 in MH, 67.59 in MS and 66.25 in DM group. Most common form of AF …

medicine.medical_specialtyobesitybusiness.industrySpecialties of internal medicineAtrial fibrillation030204 cardiovascular system & hematologymedicine.diseasemetabolic syndrome03 medical and health sciences0302 clinical medicineRC581-951diabetes mellitusEndocrinology diabetologymedicineatrial fibrillation030212 general & internal medicineIntensive care medicinebusinessRomanian Journal of Diabetes Nutrition and Metabolic Diseases
researchProduct

Running away from cardiovascular disease at the right speed: The impact of aerobic physical activity and cardiorespiratory fitness on cardiovascular …

2020

Higher levels of physical activity (PA) and cardiorespiratory fitness (CRF) are associated with lower risk of incident cardiovascular disease (CVD). However, the relationship of aerobic PA and CRF with risk of atherosclerotic CVD outcomes and heart failure (HF) seem to be distinct. Furthermore, recent studies have raised concerns of potential toxicity associated with extreme levels of aerobic exercise, with higher levels of coronary artery calcium and incident atrial fibrillation noted among individuals with very high PA levels. In contrast, the relationship between PA levels and measures of left ventricular structure and function and risk of HF is more linear. Thus, personalizing exercise …

medicine.medical_specialtyphysical activityheart failureDisease030204 cardiovascular system & hematologyLower risksydämen vajaatoimintaCoronary artery disease03 medical and health sciences0302 clinical medicinepreventionInternal medicinemedicineAerobic exerciseatrial fibrillation030212 general & internal medicineSubclinical infectionkuntoliikuntabusiness.industryAtrial fibrillationCardiorespiratory fitnessaerobinen harjoittelueteisvärinämedicine.diseasefitnessfyysinen kuntoHeart failuresydän- ja verisuonitauditCardiologyCardiology and Cardiovascular Medicinebusinesscoronary artery diseasefyysinen aktiivisuusProgress in Cardiovascular Diseases
researchProduct

Principal component analysis and cluster analysis for measuring the local organisation of human atrial fibrillation

2001

The distribution of atrial electrogram types has been proposed to characterise human atrial fibrillation. The aim of this study was to provide computer procedures for evaluating the local organisation of intracardiac recordings during AF as an alternative to off-line manual classification. Principal components analysis (PCA) reduced the data set to a few representative activations, and cluster analysis (CA) measured the average dissimilarity between consecutive activations of an intracardiac signal. The data set consisted of 106 bipolar signals recorded on 11 patients during electrophysiological studies for catheter ablation. Performances of PCA and CA in distinguishing between organised (t…

medicine.medical_treatmentBiomedical EngineeringPrincipal component analysiCatheter ablationDisease clusterIntracardiac injectionElectrocardiographyComputer analysismedicineCluster AnalysisHumansCluster analysimedicine.diagnostic_testbusiness.industrySignal Processing Computer-AssistedComputer Science Applications1707 Computer Vision and Pattern RecognitionAtrial fibrillationPattern recognitionmedicine.diseaseAtrial fibrillationComputer Science ApplicationsData setPrincipal component analysisCatheter AblationArtificial intelligencebusinessElectrocardiographyBiomedical engineeringMedical and Biological Engineering and Computing
researchProduct

Pharmacokinetics of new oral anticoagulants: implications for use in routine care

2018

Introduction: Since 2008, new oral anticoagulants (NOACs) have been approved for the prevention of venous thromboembolism (VTE) in patients receiving hip or knee replacement surgery, prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF), treatment of deep vein thrombosis (DVT), and pulmonary embolism (PE). Premarketing randomized clinical trials (RCTs) of NOACs demonstrated their non-inferiority in terms of efficacy vs. warfarin (traditional oral anticoagulant–TOA), with lower risk of serious adverse drug reactions, especially cerebral hemorrhages. In clinical practice, pharmacokinetic aspects of NOACs have to be carefully taken into account to …

medicine.medical_treatmentnew oral anticoagulantsAdministration OralKnee replacement030204 cardiovascular system & hematologyToxicologyAdherence Bleeding Interactions New oral anticoagulants Over- and under-dosage Persistence Pharmacokinetics Real World Evidence0302 clinical medicineAtrial Fibrillationover- and underdosage030212 general & internal medicinepharmacokineticStrokeRoutine careRandomized Controlled Trials as Topicnew oral anticoagulantAtrial fibrillationpersistenceVenous ThromboembolismGeneral MedicinePulmonary embolismStrokepharmacokineticsHumanmusculoskeletal diseasesmedicine.medical_specialtyinteractionHemorrhageMedication Adherence03 medical and health sciencesPharmacokineticsmedicineHumansReal World EvidenceIn patientOver- and under-dosagecardiovascular diseasesreal-world evidenceIntensive care medicineAgedPharmacologybusiness.industryAnticoagulantAnticoagulantsinteractionsbleedingmedicine.diseaseAdherencePulmonary EmbolismbusinessVenous thromboembolismExpert Opinion on Drug Metabolism & Toxicology
researchProduct

The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

2017

BACKGROUND: GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non-vitamin K antagonist oral anticoagulant (NOAC), became available.OBJECTIVES: This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase 1.METHODS: During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis des…

oral anticoagulationCross-Sectional StudieMaleRegistrieFibrinolytic AgentInternationalityAntithrombinMedizinregistryMiddle AgedAntithrombinsDabigatranStrokeProspective StudieCross-Sectional StudiesFibrinolytic AgentsAtrial FibrillationJournal ArticleHumansFemaleProspective StudiesRegistriesCardiology and Cardiovascular MedicineAgedHuman
researchProduct

Pirmreizējas sirds ritma izmaiņas pacientiem pēc atvērtās sirds operācijas

2019

Pēcoperācijas ātriju fibrilācija (POĀF) ir biežākā komplikācija pacientiem, kuriem veikta operācija uz atvērtas sirds. Kā rezultātā tā ietekmē morbiditāti, mortalitāti, kā arī palielina finansiālas izmaksas. Pētījuma mērķis ir uzzināt vai ir korelācija starp veiktiem pirms operācijas standarta izmeklējuma rezultātiem un pēcoperācijas ātriju fibrilāciju. Jo nosakot augsta riska pacientu var uzsākt preventīvu ārstēšanu. Materiāli un metodes: retrospektīvs pētījums, kur tika iekļauti pacienti, kam veikta sirds operācija ar sternotomijas pieeju, kuriem pirms operācijas bija sīnusa ritms n = 111. 39 pacienti netika iekļauti pētījumā, jo pirms operācijas bija ātriju fibrilācija vai anamnēzē ātrij…

postoperative atrial fibrillationcoronary artery bypass graftingpredictors of postoperative atrial fibrillationcardiopulmonary bypassMedicīna
researchProduct

Gut microbiome and atrial fibrillation - results from a large population-based study

2023

Background Atrial fibrillation (AF) is an important heart rhythm disorder in aging populations. The gut microbiome composition has been previously related to cardiovascular disease risk factors. Whether the gut microbial profile is also associated with the risk of AF remains unknown. Methods We examined the associations of prevalent and incident AF with gut microbiota in the FINRISK 2002 study, a random population sample of 6763 individuals. We replicated our findings in an independent case–control cohort of 138 individuals in Hamburg, Germany. Findings Multivariable-adjusted regression models revealed that prevalent AF (N = 116) was associated with nine microbial genera. Incident AF (N = 5…

rytmihäiriötmetagenomicsCardiovascular and Metabolic Diseasessuolistomikrobistosydän- ja verisuonitauditgut microbiomeatrial fibrillationepidemiologyriskitekijätepidemiologiaeteisvärinä
researchProduct

Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry

2009

We conducted meta-analyses of genome-wide association studies (GWAS) for atrial fibrillation (AF) in participants from five community-based cohorts. Meta-analyses of 896 prevalent (15,768 referents) and 2,517 incident (21,337 referents) AF cases identified a novel locus for AF (ZFHX3, rs2106261, risk ratio [RR]=1.19; P=2.3×10−7), an association that was replicated in the German AF Network (odds ratio=1.44; P=1.6×10−11). Combining the discovery and replication results, rs2106261 was significantly associated with AF (RR=1.25; P=1.8×10−15).

single nucleotideEuropean Continental Ancestry Group/*geneticsmedicine.medical_specialtyMutation/*geneticsGenome-wide association study030204 cardiovascular system & hematologyBiologyPolymorphism Single NucleotideArticleWhite PeoplepolymorphismHomeodomain Proteins/*genetics03 medical and health sciences0302 clinical medicineMeta-Analysis as TopicInternal medicineAtrial FibrillationGeneticsmedicineHumansGenetic Predisposition to Disease030304 developmental biologyGenetic associationHomeodomain Proteinsddc:6160303 health sciencesAtrial Fibrillation/*geneticsReproducibility of ResultsAtrial fibrillationOdds ratioPolymorphism Single Nucleotide/geneticsmedicine.disease*Genetic Predisposition to DiseaseMeta-analysisRelative riskMutationCohortepidemiologyChromosomes Human Pair 16/geneticsChromosomes Human Pair 16Genome-Wide Association StudyNature Genetics
researchProduct